Ceredex Value Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-654,792
Closed -$76M 183
2024
Q4
$76M Buy
654,792
+495,625
+311% +$62.7M 1.53% 12
2024
Q3
$21.5M Sell
159,167
-12,287
-7% -$1.64M 0.42% 79
2024
Q2
$23.3M Sell
171,454
-388,968
-69% -$52.9M 0.44% 83
2024
Q1
$72.4M Sell
560,422
-248,882
-31% -$30.1M 1.27% 20
2023
Q4
$92.6M Buy
809,304
+59,194
+8% +$5.91M 1.6% 14
2023
Q3
$68.3M Buy
+750,110
New +$77.4M 1.2% 26
2020
Q1
Sell
-741,550
Closed -$58.4M 181
2019
Q4
$58.4M Buy
741,550
+72,850
+11% +$5.67M 0.67% 63
2019
Q3
$53.2M Buy
668,700
+83,100
+14% +$6.53M 0.63% 67
2019
Q2
$49M Sell
585,600
-167,750
-22% -$13.4M 0.6% 65
2019
Q1
$59.5M Buy
753,350
+157,700
+26% +$11.5M 0.73% 53
2018
Q4
$39.7M Buy
+595,650
New +$41.2M 0.53% 72

Other funds holding XYL

Ceredex Value Advisors's XYL Position: Q1 2025 in Review

Ceredex Value Advisors sold out of Xylem (XYL) in Q1 2025, closing a stake of 654,792 shares — an estimated $76M sold.

Ceredex Value Advisors first reported a position in XYL in Q4 2018 and held it in 11 quarters. The position peaked at $92.6M in Q4 2023. 1,026 funds tracked by Wall St. Rank hold XYL as of Q1 2025.

  • Ceredex Value Advisors reported no remaining Xylem position as of Q1 2025 after selling out during the quarter.
  • Ceredex Value Advisors sold 654,792 Xylem shares in Q1 2025, an estimated $76M.
  • Ceredex Value Advisors first reported a position in Xylem in Q4 2018 and held it in 11 quarters.
  • Ceredex Value Advisors's Xylem position peaked at $92.6M in Q4 2023.
  • 1,026 funds tracked by Wall St. Rank held Xylem as of Q1 2025.

Based on Ceredex Value Advisors's 13F filing for Q1 2025, filed 14 May 2025.